MOUNJARO KWIKPEN 2.5 mg (Tirzepatide)

Prescription Mandatory

Mounjaro KwikPen 2.5 mg contains tirzepatide, a once-weekly injectable medicine commonly used as a starting dose to improve blood sugar control in adults with type 2 diabetes. It works by activating GIP and GLP-1 receptors to support insulin secretion and appetite control.

Manufacturer	Eli Lilly and Company
Generic Name	Tirzepatide
Strength	2.5mg
Package size	1 pre-filled 2.4 ml pen
Used for	Type 2 diabetes and weight control
Availability	In Stock
Shipping to	USA, UK, Australia, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Saudi Arabia, Qatar, Kuwait, and many other countries.

Ask Price on WhatsApp

Authentic Medicines

Fast Delivery

Secure Payment

24/7 Support

Uses of MOUNJARO KWIKPEN 2.5 mg

Treats type 2 diabetes mellitus.
Helps control high blood sugar levels.
Used for weight management in some patients.
Improves insulin sensitivity.

Benefits of MOUNJARO KWIKPEN 2.5 mg

Lowers blood glucose effectively.
Supports weight loss.
Reduces appetite.
Improves long-term sugar control (HbA1c).
May reduce risk of diabetes complications.

How Does It Work?

Tirzepatide is a dual GIP and GLP-1 receptor agonist. It increases insulin release when blood sugar is high, reduces glucagon levels, slows digestion, and decreases appetite, helping control blood sugar and body weight.

Precautions

Take exactly as prescribed (weekly injection).
Do not change dose without medical advice.
May cause nausea or vomiting initially.
Monitor blood sugar regularly.
Inform doctor about pancreas or thyroid issues.
Use caution in kidney or liver disease.
Report severe abdominal pain immediately.
Follow diet and exercise plan.

Side Effects

Nausea
Vomiting
Diarrhea
Decreased appetite
Constipation